Arne Nedergaard Koshoult

Company: The Netherlands Cancer Institute
Job title: Postdoc
Seminars:
Addressing DDRi Toxicity: Dosing Schedules, Combination Studies & Biomarkers 9:00 am
Weighing up the costs and benefits of alternative dosing schedules and tailoring them to specific patients Refining specificity: targeting tumors using the different screening platform Evaluating common biomarker approaches to patient selection: BRCA screening, HHR gene panel tests and HRD genomic instability assaysRead more
day: Day Two